Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection
Recruiting · NCT06970288 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.
Who can take part
Age range
30 Years to 50 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- • Women with suspicious breast mass (BIRADS 4a)
- High risk women (Positive family history)
- Women with suspicious axillary lymph nodes by Ultrasound
- Women with dense breasts coming for MRI imaging.
Exclusion criteria
- • Contraindications to MRI
- Pacemaker, cochlear implant, claustrophobia, ocular implants
- Contraindications to contrast administration:
- Elevated kidney functions
- Women who haven't undergone reliable Mammogram \& Ultrasound
- Women with prior treatment or intervention (e.g. biopsy)
- Patients' refusal.
Where it is running
1 location listed.
- Ain Shams University - Cairo, Abbasia, Egypt